These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25422248)

  • 1. Serum cathepsin B to cystatin C ratio as a potential marker for the diagnosis of cholangiocarcinoma.
    Monsouvanh A; Proungvitaya T; Limpaiboon T; Wongkham C; Wongkham S; Luvira V; Proungvitaya S
    Asian Pac J Cancer Prev; 2014; 15(21):9511-5. PubMed ID: 25422248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total serum bile acid as a potential marker for the diagnosis of cholangiocarcinoma without jaundice.
    Sombattheera S; Proungvitaya T; Limpaiboon T; Wongkham S; Wongkham C; Luvira V; Proungvitaya S
    Asian Pac J Cancer Prev; 2015; 16(4):1367-70. PubMed ID: 25743800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum α1β-glycoprotein and afamin ratio as potential diagnostic and prognostic markers in cholangiocarcinoma.
    Tolek A; Wongkham C; Proungvitaya S; Silsirivanit A; Roytrakul S; Khuntikeo N; Wongkham S
    Exp Biol Med (Maywood); 2012 Oct; 237(10):1142-9. PubMed ID: 23104505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of new biomarkers for cholangiocarcinoma.
    Miwa M; You G; Tanaka H; Taniguchi S; Fujii T; Kamemura K; Suzaki M; Isono T; Tooyama I; Tanaka M; Srivatanakul P; Viwatthanasittiphong C; Sangrajrang S; Khuhaprema T
    J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):397-8. PubMed ID: 24446393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Serum Glycobiomarker for Diagnosis and Prognosis of Cholangiocarcinoma Detected by
    Teeravirote K; Luang S; Waraasawapati S; Boonsiri P; Wongkham C; Wongkham S; Silsirivanit A
    Molecules; 2021 May; 26(9):. PubMed ID: 34066878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Bile Titer and High Bile to Serum Ratio of CYFRA 21 - 1 Reliably Discriminate Malignant Biliary Obstruction Caused by Cholangiocarcinoma.
    Chen J; Liang J; Xu B; Liang J; Ma M; Wang Z; Zeng G; Xu Q; Liang L; Lai J; Huang L
    J Gastrointest Cancer; 2024 Jun; 55(2):800-808. PubMed ID: 38280173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Promising Serum Autoantibody Marker, Anti-Heat Shock Protein 90α, for Cholangiocarcinoma.
    Boonjaraspinyo S; Juasook A; Boonmars T; Aukkanimart R; Silsirivanit A; Loilome W; Sriraj P; Wu Z; Ratanasuwan P
    Asian Pac J Cancer Prev; 2015; 16(14):5779-85. PubMed ID: 26320451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristic Features of Cholangiocarcinoma Complicating Primary Sclerosing Cholangitis.
    Ishii Y; Sasaki T; Serikawa M; Kobayashi K; Kamigaki M; Minami T; Okazaki A; Yukutake M; Ishigaki T; Kosaka K; Mouri T; Yoshimi S; Chayama K
    Hepatogastroenterology; 2014 May; 61(131):567-73. PubMed ID: 26176037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptidase inhibitor 15 as a novel blood diagnostic marker for cholangiocarcinoma.
    Jiang Y; Zheng X; Jiao D; Chen P; Xu Y; Wei H; Qian Y
    EBioMedicine; 2019 Feb; 40():422-431. PubMed ID: 30638862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Apurinic/Apyrimidinic Endodeoxyribonuclease 1 (APEX1) Level as a Potential Biomarker of Cholangiocarcinoma.
    Tummanatsakun D; Proungvitaya T; Roytrakul S; Limpaiboon T; Wongkham S; Wongkham C; Silsirivanit A; Somintara O; Sangkhamanon S; Proungvitaya S
    Biomolecules; 2019 Aug; 9(9):. PubMed ID: 31454981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile-derived circulating extracellular miR-30d-5p and miR-92a-3p as potential biomarkers for cholangiocarcinoma.
    Han HS; Kim MJ; Han JH; Yun J; Kim HK; Yang Y; Kim KB; Park SM
    Hepatobiliary Pancreat Dis Int; 2020 Feb; 19(1):41-50. PubMed ID: 31784323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Detection of Cholangiocarcinoma in Primary Sclerosing Cholangitis Patients: Single Center Experience.
    Kuzu UB; Ödemiş B; Suna N; Yıldız H; Parlak E; Dişibeyaz S; Torun S; Akpınar MY; Coşkun O; Turhan N; Yüksel M; Kayaçetin E
    J Gastrointest Cancer; 2016 Mar; 47(1):8-14. PubMed ID: 26537791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator.
    Silakit R; Loilome W; Yongvanit P; Chusorn P; Techasen A; Boonmars T; Khuntikeo N; Chamadol N; Pairojkul C; Namwat N
    J Hepatobiliary Pancreat Sci; 2014 Dec; 21(12):864-72. PubMed ID: 25131257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma hydroxyproline, MMP-7 and collagen I as novel predictive risk markers of hepatobiliary disease-associated cholangiocarcinoma.
    Prakobwong S; Charoensuk L; Hiraku Y; Pinlaor P; Pairojkul C; Mairiang E; Sithithaworn P; Yongvanit P; Khuntikeo N; Pinlaor S
    Int J Cancer; 2012 Aug; 131(4):E416-24. PubMed ID: 21935919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional profiles of peripheral blood leukocytes identify patients with cholangiocarcinoma and predict outcome.
    Subimerb C; Wongkham C; Khuntikeo N; Leelayuwat C; McGrath MS; Wongkham S
    Asian Pac J Cancer Prev; 2014; 15(10):4217-24. PubMed ID: 24935374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improve discrimination power of serum markers for diagnosis of cholangiocarcinoma using data mining-based approach.
    Pattanapairoj S; Silsirivanit A; Muisuk K; Seubwai W; Cha'on U; Vaeteewoottacharn K; Sawanyawisuth K; Chetchotsak D; Wongkham S
    Clin Biochem; 2015 Jul; 48(10-11):668-73. PubMed ID: 25863112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum miR-26a as a diagnostic and prognostic biomarker in cholangiocarcinoma.
    Wang LJ; Zhang KL; Zhang N; Ma XW; Yan SW; Cao DH; Shi SJ
    Oncotarget; 2015 Jul; 6(21):18631-40. PubMed ID: 26087181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Resolvin D1 in the Differential Diagnosis of the Cholangiocarcinoma and Benign Biliary Diseases.
    Gül-Utku Ö; Karatay E; Ergül B; Kisa Ü; Erdin Z; Oğuz D
    Clin Lab; 2020 May; 66(5):. PubMed ID: 32390401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imbalanced serum concentration between cathepsin B and cystatin C in patients with pelvic inflammatory disease.
    Tsai HT; Wang PH; Tee YT; Lin LY; Hsieh YS; Yang SF
    Fertil Steril; 2009 Feb; 91(2):549-55. PubMed ID: 18314113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of protein tyrosine phosphatase receptor S (PTPRS) is an independent prognostic marker for cholangiocarcinoma.
    Lertpanprom M; Silsirivanit A; Tippayawat P; Proungvitaya T; Roytrakul S; Proungvitaya S
    Front Public Health; 2022; 10():835914. PubMed ID: 35991009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.